Information
-
Trademark
-
90494961
-
International Classifications
-
Filing Date
January 28, 2021
3 years ago
-
Transaction Date
June 13, 2024
4 months ago
-
Status Date
June 13, 2024
4 months ago
-
Published for Opposition Date
April 19, 2022
2 years ago
-
Location Date
June 14, 2022
2 years ago
-
Status Code
733
-
Current Location
INTENT TO USE SECTION
Employee Name
NGUYEN, NICOLE ASHLEY
-
Attorney Docket Number
189898.00040
Law Office Assigned Location Code
M50
-
Owners
Mark Drawing Code
4
Mark Identification
DETERMACNI
Case File Statements
- GS0051: Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
- GS0011: Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
- GS0441: Medical services, namely, providing blood testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
- GS0101: Biopsy tests and devices, namely, medical instruments for use in performing blood-based testing and medical diagnostic apparatus for testing changes in biomarkers; cancer screening tests and devices, namely, medical devices for post-cancer treatment reoccurrence monitoring; medical diagnostic apparatus for testing patients' post-cancer treatment biomarkers
- GS0421: Providing blood reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
Case File Event Statements
-
2/1/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/30/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/17/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/23/2021 - 3 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/23/2021 - 3 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
8/23/2021 - 3 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/23/2022 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/23/2022 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/23/2022 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/14/2022 - 2 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/30/2022 - 2 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/19/2022 - 2 years ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/19/2022 - 2 years ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/14/2022 - 2 years ago
14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
11/14/2022 - a year ago
15 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
11/14/2022 - a year ago
16 - SOU EXTENSION 1 FILED
Type: EXT1
-
11/14/2022 - a year ago
17 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
11/16/2022 - a year ago
18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/6/2023 - a year ago
19 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/6/2023 - a year ago
20 - SOU EXTENSION 2 FILED
Type: EXT2
-
6/6/2023 - a year ago
21 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
6/9/2023 - a year ago
22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/5/2023 - 11 months ago
23 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
12/5/2023 - 11 months ago
24 - SOU EXTENSION 3 FILED
Type: EXT3
-
12/5/2023 - 11 months ago
25 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
1/12/2024 - 9 months ago
27 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/13/2024 - 4 months ago
28 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/13/2024 - 4 months ago
31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/13/2024 - 4 months ago
29 - SOU EXTENSION 4 FILED
Type: EXT4
-
6/13/2024 - 4 months ago
30 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
12/7/2023 - 11 months ago
26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA